Melissa Lueke

Melissa Lueke is a declared insider of Meridian Bioscience Inc, with filings sourced from SEC (Form 4). We count 61 filings; the first trade dates from 3 November 2006 and the latest from 15 December 2018.

In open-market terms, that means 1 purchase worth €47k on one side and 10 sales worth €1.5M on the other. Taken together, the sales exceed the purchases by €1.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 30 share grants and 10 option exercises.

The latest filing, published on 25 February 2019, reports a share grant of €20k in Meridian Bioscience Inc. The clock since the last published purchase (3 February 2017) now reads 3,565 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.